ArticleCancers2024

Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients.

Andrea J Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.